Gen9 Awarded Four U.S. Patents for Innovation in Synthetic Biology

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gen9 issued four new U.S. patents to further strengthen the Company’s already extensive intellectual property portfolio to more than 100 patents and patents pending.
Source: BusinessWire-Primary

Gen9 Awarded Four U.S. Patents for Innovation in Synthetic Biology